ANNUAL REPORT April 2015 March 2016
|
|
- Ruby Bradley
- 6 years ago
- Views:
Transcription
1 ANNUAL REPORT INFECTION PREVENTION AND CONTROL April 2015 March 2016 Prepared by: Provincial Health Services Authority Infection Prevention & Control August P age
2 Table of Contents Table of Contents... 1 Executive Summary... 2 PHSA Infection Prevention and Control Program... 3 Knowledge Translation... 7 Hand Hygiene Program Cleaning, Disinfection and Sterilization Construction Consultation Surveillance Outbreak Management Projects and Initiatives Future Directions Appendix A PHSA IPAC Organizational Chart Appendix B Definitions P age
3 Executive Summary At the Provincial Health Services Authority (PHSA), the safety of patients, staff and visitors is of ultimate importance. To help meet this commitment, a PHSA Infection Prevention and Control (IPAC) Service was formed in 2006, reporting to the PHSA VP of Quality and Safety. The IPAC team works collaboratively with other groups within PHSA, other health authorities, the Provincial Infection Control Network of BC (PICNet), and regional and national public health services in supporting best practices to prevent and control infections at PHSA facilities. The IPAC team is involved in a variety of activities that include: Knowledge translation (education and research) Hand hygiene program Surveillance Outbreak management Construction consultation Cleaning, disinfection and sterilization Policy and procedure development During , the IPAC team participated in additional projects and initiatives such as: Conducting a PHSA-wide survey on staff perceptions of the IPAC Service Implementation of the UV-C disinfection machine at BC Children s Hospital Development of a new C-section surveillance system at BC Women s Hospital + Health Centre The following table highlights trends in HAI rates for : Indicator Rate Rate PHSA Overall Hand Hygiene Compliance 90% 92% PHSA HA-CDI Rate 6.9 per 10,000 inpatient 6.4 per 10,000 inpatient days days PHSA HA-MRSA Rate 2.3 per 10,000 inpatient 2.9 per 10,000 inpatient days days PHSA HA-VRE Rate 0.5 per 10,000 inpatient 1.7 per 10,000 inpatient days days CRBSI Rate in PICU 0.6 per 1, per 1,000 catheter days catheter days CRBSI Rate in NICU 2.4 per 1, per 1,000 catheter days catheter days *NOTE: None of the above rate changes are statistically significant. 2 P age
4 PHSA Infection Prevention and Control Program Our vision: Empowering everyone to prevent infections. These words paint a picture of the world the Infection Prevention and Control (IPAC) Service seeks to create. Our vision captures the notion that each person in the healthcare team has a role to play in the prevention of infections. Our goal is to ensure that everyone has the knowledge and confidence to participate in infection prevention. Our mission: Our mission is to ensure the protection of patients, staff and visitors from preventable infections. We aim to achieve this through: A proactive approach to current and evolving challenges Facilitating implementations and solutions Expert consultation based on applicable regulations, evidence and best practice Collaborating with local, provincial, and national partners Our services: Knowledge Translation Hand Hygiene Program Surveillance Outbreak Management Construction Consultation Cleaning, Disinfection and Sterilization Projects and Initiatives Policies and procedures 3 P age
5 PHSA Infection Prevention and Control Team Georgene Miller, RN, MSN Vice President Quality Safety and Outcome Improvement Jocelyn Srigley, MD, FRCPC Corporate Director, PHSA IPAC Medical Microbiologist Ghada Al-Rawahi, MD, FRCPC IPAC Medical Lead, BCCA Medical Microbiologist Simon Dobson, MD, FRCPC Infection Control Officer Infectious Diseases Specialist Peter Tilley, MD, FRCPC Infection Control Officer Medical Microbiologist David Goldfarb, MD, FRCPC Infection Control Officer Medical Microbiologist Robyn Hunter, RN, CIC PHSA IPAC Coordinator Stacie Buttar, HR IPAC Administrative Assistant Jun Chen Collet, BMed, MSc IPAC Epidemiologist Viola Tang, RN IPAC Reprocessing Manager Sarah Wells, BHSc, CIC IPAC Construction Specialist Louise Holmes, RN, BSN Clinical Project Lead Redevelopment Marney Hunt, RN, BSN Infection Control Practitioner, BCCH & BCWH Charina Rivas, RN, BSN Infection Control Practitioner, BCCH & BCWH Julita Sienkiewicz, RN, BSN Infection Control Practitioner, BCCH & BCWH Alison Chant, RN, CIC Infection Control Practitioner, BCCA Kimberly Mallory, RN, CIC Infection Control Practitioner, BCCA Sheetal Kainth, RN Infection Control Practitioner, BCCA Kristie Harding, RN Infection Control Practitioner, BCCA Judy Tearoe, RN Infection Control Practitioner, BCCA Adriana Mendes, RN, CIC Infection Control Practitioner, BCCA May Tang, RN Infection Control Practitioner, BCCA KaWai Leung, RN, MPH Infection Control Practitioner, BCCA Ron Morley, RPN, ADPN Infection Control Practitioner, Forensics Lisa Young, RN, BA(Hons) Leader, IPAC, BCEHS Carmen Saucier Hand Hygiene Auditor, Co-op Student Rishi Chatterjee Hand Hygiene Auditor, Co-op Student Cherrie Lo Hand Hygiene Auditor, Co-op Student Sanjam Jhawar Hand Hygiene Auditor, Co-op Student Michelle Chang, RN, MPH Infection Control Practitioner, BCCH &BCWH 4 P age
6 Our Facilities: BC Centre for Disease Control: New Westminster and Vancouver Clinics Annual outpatient visits TB Clinic: 20,568 Annual outpatient visits STD Clinic: 18,277 BC Children s Hospital Acute care beds: 102 Annual admissions: 6,587 Annual outpatient visits: 130,578 BC Child and Youth Mental Health Acute care beds: 40 Annual admissions: 395 Annual outpatient visits: 17,103 Sunny Hill Health Centre for Children Acute care beds: 14 Annual admissions: 134 Annual outpatient visits: 10,929 BC Women s Hospital Acute care beds: 130 Annual admissions: 16,177 Annual outpatient visits: 60,373 4 P age
7 BC Cancer Agency Vancouver Centre* Acute care beds: 26 Annual admissions: 729 Annual outpatient visits: 126,558 BC Cancer Agency Vancouver Island Centre* Acute care beds: N/A Annual admissions: N/A Annual outpatient visits: 69,789 BC Cancer Agency Abbotsford Centre* Acute care beds: N/A Annual admissions: N/A Annual outpatient visits: 43,171 BC Cancer Agency Centre of the Southern Interior* Acute care beds: N/A Annual admissions: N/A Annual outpatient visits: 50,923 BC Cancer Agency Centre of the North* Acute care beds: N/A Annual admissions: N/A Annual outpatient visits: 18,195 BC Cancer Agency Fraser Valley Centre* Acute care beds: N/A Annual admissions: N/A Annual outpatient visits: 61,146 5 P age
8 BC Forensic Psychiatric Hospital Acute care beds: 190 Annual admissions: 283 Annual outpatient visits: 2,590 BC Emergency Health Services (A division supported by PHSA) # Ambulances dispatched: 545,000 # Air ambulance annual calls: 6,700 N/A indicates that this activity is not applicable. *The outpatient visits for BCCA are the sum of the radiation therapy visits, systemic therapy visits and chemotherapy visits. Source: Data provided by PHSA Performance Measurement and Reporting Group. 6 P age
9 Knowledge Translation Staff, Volunteer, Patient, Family, and Visitor Education Education is an essential component of IPAC. The IPAC team delivers education sessions to all new employees during orientation and provides ongoing education to all PHSA staff. During , IPAC provided 9,090 hours of educational sessions for 2,118 staff. In addition to didactic sessions, the infection control practitioners (ICPs) address patient-, procedure-, or unitspecific concerns on a daily basis through phone consultation and ward visits. International Infection Control Week (October 19-23, 2015) was another opportunity to provide education to staff, as well as volunteers, patients, families and visitors. Daily newsletters were sent to all staff on topics that included methicillinresistant Staphylococcus aureus (MRSA), Clostridium difficile (C. difficile) infection, influenza, and shingles (herpes zoster). The IPAC team is continually developing, assessing and revising education material and strategies to meet learning needs. The BC Infection Control and Hand Hygiene course, Hand Hygiene for Medical Staff, and Provincial Hand Hygiene Basics are available online for all staff through the Learning Hub ( ). Information sheets on IPAC topics are available for staff, patients, families, and visitors through the PHSA Libraries ( 7 P age
10 Continuing Education for the IPAC Team IPAC leadership encourages self-led knowledge enhancement and development to ensure that all team members remain up to date with IPAC best practices. Support is provided for team members to attend various learning opportunities such as national infection control education conferences (IPAC Canada), provincial educational days (e.g. Provincial Infection Control Network, IPAC-BC), Canadian Standards Association seminars, web teleclasses, Infectious Diseases/Medical Microbiology rounds at BC Children s and BC Women s and Oncology rounds at BC Cancer Agency. In addition, Dr. Michael Gardam, Director of IPAC at the University Health Network in Toronto was invited to present to the team in November 2015 on the topic of frontline ownership and culture change. IPAC team members are also encouraged to pursue formal education and certification programs (e.g. Certification in Infection Control). Research Activities: Peer-reviewed publications: Leduc S, Busch K, Campbell J, Cassidy K, Collet JC, Forrester L, Henderson E, Leal J, Leamon A, Pelude L, Mitchell R, Mukhi SN, Quach-Thanh C, Shurgold JY, Simmonds K. What can an audit of national surveillance data tell us? Findings from an audit of Canadian vancomycin-resistant enterococci surveillance data. Canadian J Infect Control 2015; 30(2): Srigley JA, Corace K, Hargadon DP, Yu D, MacDonald T, Fabrigar L, Garber G. Applying psychological frameworks of behaviour change to improve healthcare worker hand hygiene: a systematic review. J Hosp Infect 2015;91(3): Conference abstracts: Wong F, Prestley N, Dhillon S, Albert A, Collet JC, Thomas E, Van Schalkwyk J, Money D, Dewar K, Hippman C, Shaw D, Giesbrecht E. Improving post-discharge surveillance of surgical site infection following caesarean section at BC Women s Hospital. Poster presentation at Quality Forum, Vancouver, British Columbia. February Lavie-Nevo K, Ting JY, Al-Rawahi G, Paquette V, Osiovich H, Dobson S, Roberts A. Prevalence and clinical impact of methicillin-resistant Staphylococcus aureus colonization and infection among infants at a level III neonatal intensive care unit. Poster presentation at Pediatric Academic Societies Meeting, San Diego, California. April P age
11 Harding K, Al-Rawahi G, Chant A, Hunter R, Tearoe J, Ryder B, Kainth S. Genetically modified micro-organisms to treat cancer: infection control implications. Poster presented at IPAC Canada National Education Conference, Victoria, British Columbia. June Laporte K, Collet JC, Thomas E, Tilley P, Dobson S, Hunter R, Hunt M, Al-Rawahi G. A norovirus outbreak amongst a pediatric oncology patient population. Poster presented at IPAC Canada National Education Conference, Victoria, British Columbia. June Lloyd-Smith E, Collet JC, Donovan T, Forrester L, Han G, Leamon A, Mori J. Formation of Infection Control Epidemiologists in British Columbia: setting the stage for collaboration. Oral presentation by L Forrester at IPAC Canada National Education Conference, Victoria, British Columbia. June Srigley JA, Corace K, Hargadon DP, Yu D, MacDonald T, Fabrigar L, Garber G. Can behaviour change theory help us improve healthcare worker hand hygiene compliance? A systematic review. Oral presentation by K. Corace at IPAC Canada National Education Conference, Victoria, British Columbia. June Corace K, Srigley JA, Hargadon DP, Yu D, MacDonald T, Fabrigar L, Garber G. Can behavior change frameworks improve healthcare worker influenza vaccination uptake? A systematic review. Poster presentation at IDWeek 2015, San Diego, California. October Bedford J, Ting J, Paquette V, Ng K, Tilley P, Murthy S, Rassekh S, Kang K, Osiovich H, Roberts A, Skarsgard E, Dobson S, Ting J. Antimicrobial prophylaxis and the risk of surgical site infections: a national surgical quality improvement program-pediatrics (NSQIP) analysis. Poster presentation at World Congress of Pediatric Infectious Diseases Annual Conference, Rio De Janerio, Brazil. November P age
12 Collaborations: Since 2002, BC Children s Hospital and BC Women s Hospital + Health Centre have actively participating in the Canadian Nosocomial Infection Surveillance Program s surveillance and research initiatives. The IPAC team will continue to contribute to this national collaboration and help our national colleagues to generate evidence-based data that can be used to establish benchmarks, identify trends, and develop provincial/national guidelines to help reduce the transmission of HAIs. In 2015, PHSA IPAC joined the Society for Healthcare Epidemiology of America (SHEA) Research Network, an international consortium of over 100 facilities collaborating on multicentre research projects. IPAC team members participated in a number of surveys through this network. In early 2016, PHSA was recognized by the SHEA Research Network as being a top contributor. On February 16, 2016, the IPAC team at BCWH participated in a national antibiotic resistant organism (ARO) point prevalence survey. This was a follow-up to similar surveys that occurred in 2010 and 2012, with the aim of defining the burden of AROs in Canadian hospitals, and in particular to further determine trends and changes that occur over time. Publication of the results is anticipated in the next fiscal year. 10 P age
13 Hand Hygiene Program Hand Hygiene is considered an important intervention to prevent the spread of healthcareassociated infections. The PHSA hand Hygiene (HH) program began in The BC Ministry of Health Best Practices for Hand Hygiene document guides hand hygiene practice for all facilities at PHSA. Major HH Activities in : Update of electronic HH auditing system. A celebration of World HH Day occurred in May. The focus was on encouraging PHSA staff to submit HHrelated photos to the Canada-wide Clean Shots campaign. Audits continue to be done quarterly with outstanding results. Major refresh of the promotional materials was undertaken with Emily Carr University of Art and Design, which included input from staff, patients and families. Change of HH soap occurred. HH continues to be a regular topic for in-services and orientation. High Achievers This Year: BC Cancer Agency CN Radiation Therapy (100 per cent) BC Centre for Disease Control STI Vancouver (95.5 per cent) BCCH Sunny Hill (97 per cent) BCWH Neonatal Intensive Care Unit (93 per cent ) Forensice Psychiatric Hospital A2 (99 per cent ) Centre for Youth Mental Health Child and Adolescent Psychiatric Emergency (94 per cent ) Figure 1: The trend of PHSA overall HH compliance 11 P age
14 Cleaning, Disinfection and Sterilization BC Children s and BC Women s floor cleaning equipment review In late 2014, the IPAC Service conducted a review of the floor cleaning procedures and cleaning equipment maintenance provided by Environmental Services in response to increased levels of dust and spores generated during floor cleaning on a closed unit during terminal cleaning. This review revealed a lack of procedures for cleaning and care of equipment. The IPAC Service made recommendations to Environmental Services on the use, maintenance and cleaning of floor cleaning equipment. Since these recommendations were issued in November 2014, Environmental Services has developed cleaning and maintenance procedures and there are dedicated machines for patient care areas only to be used when patients are not present. Housekeeping Audits BC Centre for Disease Control In February 2016 BCCDC contracted Westech Systems for routine housekeeping auditing at the Vancouver clinics (TB and STI) and the New Westminster TB clinic. Westech uses visual and ultraviolet (UV) markers to audit housekeeping practices, whereas prior to this only visual auditing was completed. The UV marker is applied to surfaces and is easily removed with normal cleaning. If cleaning was not done, the surface will show the mark under UV light. The first audit with Westech Systems was conducted in the Vancouver Clinics and New Westminster Clinic in March and April 2016, respectively. Visual audits showed an average score of 65 per cent and UV marker audits revealed a score of 16 per cent. Audit results are shared with the clinic leadership and WSI (housekeeping) leadership so that improvements can be made where necessary. Rapid Disinfector TM Machine In January 2016, the IPAC Service, in collaboration with the Haematology/Oncology program and Environmental Services at BCCH, introduced the R-D TM Rapid Disinfector TM (RD machine) to the inpatient and outpatient oncology units to target the reduction of C. difficile infections in this vulnerable population. The technology uses ultraviolet C light to disinfect the patient rooms, after regular cleaning, by killing microorganisms via disruption of DNA and RNA of viruses and drugresistant bacteria, including C. difficile spores. For the 6 month pilot implementation, the RD machine was used for all oncology inpatient discharge cleans as well as for the Oncology outpatient bathrooms and apheresis rooms. This pilot implementation included a survey for oncology unit staff and Environmental Services staff. Going forward, the plan is to establish a process that best utilizes the RD machine within the existing environmental 12 P age
15 services resources, with the goal of extending RD machine use to other areas of BCCH (e.g. operating rooms). Ministry of Health Audit Results The B.C. Ministry of Health (MOH) has mandated province-wide audits for reprocessing practices of critical and semi-critical medical devices since This was implemented using a standard audit tool to improve patient safety through adoption of Table 3: PHSA medical device reprocessing compliance results ( ). Audit Section Description Assessment & purchase of medical devices & reprocessing equipment 100% 100% 100% 100% 100% 100% Environmental requirement for reprocessing area N/A N/A 92% 97% 96% 98% Policies & procedures N/A N/A 100% 100% 100% 100% Education & training 90% 99% 100% 100% 100% 100% Occupational health & safety N/A N/A 91% 97% 100% 100% Cleaning (decontamination) or reusable medical devices 96% 99% 100% 100% 99% 100% Factors affecting product selection & efficacy of liquid chemicals N/A N/A 100% 100% 100% 100% Disinfection of reusable devices 92% 99% 100% 100% 100% 99% Reprocessing endoscope devices N/A N/A 97% 100% 99% 99% Sterilization of reusable medical devices N/A N/A 100% 100% 100% 100% Storage & use of reprocessed medical devices N/A N/A 100% 100% 100% 97% Quality assurance N/A N/A 100% 100% 100% 100% Single use medical devices N/A N/A 100% 100% 100% 100% Dental clinic (providing services to a health care facility) N/A N/A 67% 67% 67% 100% Note: N/A indicates that this activity was not performed. 13 P age
16 Construction Consultation The IPAC Service is actively involved in all construction, renovation and maintenance projects within PHSA to ensure that Canadian/provincial standards and best practices are considered and adhered to. Ongoing construction activities include: o Collaboration with site multidisciplinary teams for planned construction and maintenance projects to ensure appropriate assessment of risk to the occupants of the facility. o Approval, monitoring and documentation of preventative measures installed during construction projects to ensure effective barriers between patient/client and work areas. o Consult on design during project planning phases (materials, work flow, sink and ABHR placement, etc.). o Ongoing staff education on the risk of construction activities in healthcare facilities. The Lower Mainland Facilities Management Infection Control Committee (LMFMICC) has a representative from the PHSA IPAC Service. Major construction consultation activities during include: o Collaboration with the LMFMICC to develop an online training module for frontline Facility Maintenance staff. o Review of third party infection control and air monitoring activities during the construction of the Teck Acute Care Centre at BC Children s. o At BC Cancer Agency, the Centre for the Southern Interior chemotherapy and pharmacy department underwent a redesign in order to bring prep areas and mixing rooms up to current standards. The Vancouver Island Centre Pharmacy/Ambulatory Care Unit (ACU) re-design was intended to achieve compliance with the BC College of Pharmacists Standards. In addition, there was a need to improve space efficiency within the department given the increased workload since the department was designed. The first phase of this project involved the ACU re-design, followed by renovations of the third floor conference rooms to serve as a temporary pharmacy and finally, the third phase was the complete overhaul of the pharmacy. Another exciting project at Vancouver Island Centre this year was the installation of its first Clean Room within the Deeley Research Center. This renovation was required to install specialized equipment for the manufacture of cellular therapy products as part of the Immunotherapy Program due to begin clinical trials in o At FPH, the most significant construction project that impacted patient care was the Hawthorne House washroom rebuild. Omnicell renovations occurred on all units with minimal risk posed to patients and staff as all carpentry was performed off-site. All shower pans were replaced in Ashworth due to age; barriers reduced patient and staff exposure to construction dust. 14 P age
17 Surveillance In order to implement and evaluate interventions to reduce health care-associated infections (HAIs), PHSA IPAC conducts routine surveillance on all inpatients units at PHSA facilities. This section provides information on the incidence and trends of HAIs identified among patients admitted to three PHSA facilities (BC Children s, BC Women s and BC Cancer Agency - Vancouver Centre). Clostridium difficile Infection C. difficile is a spore-forming bacterium that can live in the intestines of healthy people. It may produce toxins and cause C. difficile infection (CDI), requiring prompt recognition, testing, and treatment. In 2015/16, 95 new CDI cases were identified. Thirty three (35 per cent ) of these were classified as health care-associated CDI (HA-CDI), corresponding to a rate of 6.4 cases per 10,000 inpatient days (Figure 4). At the facility level, zero cases were identified at BCWH. A slightly decreased HA-CDI rate was found for both BCCH and BCCA compared to 2014/15 (Figure 5). The rate of HA-CDI at PHSA is driven by oncology patients (26/33), who are at high risk for CDI due to frequent broad-spectrum antibiotic treatment and compromised immune systems. Given the complex nature of CDI, it is possible that some patients carried the organism in their intestines on admission without symptoms, rather than acquiring it in a health care facility. The IPAC Service has continually made efforts to prevent HA-CDI occurrence and minimize transmission through multidisciplinary collaborative work, including 1) hand hygiene promotion; 2) stringent environmental cleaning/disinfection, including implementation of a UV disinfection machine at BCCH/BCWH; 3) timely implementation of Contact Precautions for suspected and confirmed CDI patients; 4) audits using a CDI tool kit whenever there was a trigger alert. Figure 4: Overall HA-CDI rate at PHSA acute care facilities Cases per inpatient days PHSA overall incidence rate of HA -CDI 2009/ / / / / / / / /16 PHSA HA-CDI rate P age
18 Figure 5: HA- CDI rate by acute care facility at PHSA Cases per inpatient days HA-CDI incidence rate among inpatients at PHSA acute care facilities 09/110/111/112/113/114/115/ /110/111/112/113/114/115/ /110/111/112/113/114/115/ BCCA BCCH BCWH HA-CDI Rate Methicillin-Resistant Staphylococcus aureus Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium that may colonize the skin and noses of healthy people but has the potential to cause infections with limited treatment options and life-threatening complications (e.g. pneumonia). In 2015/16, 80 new MRSA cases (including colonization and infection) were identified among patients admitted to PHSA facilities, 25 (31 per cent ) of which were classified as health careassociated MRSA (HA-MRSA). The PHSA HA-MRSA rate has increased since 2013/14, although the increase is not statistically significant (Figure 6). At the facility level, one HA-MRSA case was identified at BCCA in 2015/16. An increased rate of HA-MRSA was observed at both BC Children s and BC Women s. To prevent and control MRSA transmission, IPAC has initiated actions on targeted units with high MRSA burden, including implementation of MRSA screening compliance audits and reinforcement of appropriate hand hygiene practice. Figure 6: Overall HA-MRSA rate at PHSA acute care facilities Cases per inpatient days PHSA overall incidence rate of HA -MRSA 2009/ / / / / / / / /16 PHSA HA-MRSA Rate P age
19 Figure 7: HA- MRSA rate by acute care facility at PHSA Cases per inpatient days HA-MRSA incidence rate among inpatients at PHSA acute care facilities 09/ 10 10/ 11 11/ 12 12/ 13 13/ 14 14/ 15 15/ 16 09/ 10 10/ 11 11/ 12 12/ 13 BCCA BCCH BCWH HA_MRSA Rate / 14 14/ 15 15/ 16 09/ 10 10/ 11 11/ 12 12/ 13 13/ 14 14/ 15 15/ 16 Vancomycin-Resistant Enterococci Vancomycin-resistant enterococci (VRE) are bacteria that may colonize the intestines without causing symptoms. However some patients, particularly those with compromised immune systems or invasive devices, may develop VRE infections that are difficult to treat. In 2015/16, 34 new VRE colonization cases were identified at PHSA facilities, 16 (47 per cent ) of which were classified as health care-associated VRE (HA-VRE). Although the number is relatively small, the overall PHSA HA-VRE rate has increased since 2009/10 (Figure 8) across three PHSA facilities (Figure 9). Figure 8: Overall HA-VRE rate at PHSA acute care facilities Cases per inpatient days PHSA overall incidence rate of HA-VRE 2009/ / / / / / / / /16 PHSA HA-VRE Rate P age
20 Figure 9: HA-VRE rate by acute care facility at PHSA Carbapenemase-Producing Organisms Carbapenemase-producing organisms (CPO) are gram-negative bacteria, such as E. coli and Klebisella species, that are resistant to almost all antibiotics. They are common in certain areas of the world but are spreading and have been found in British Columbia. Most people with CPO carry the bacteria in their gastrointestinal tract and do not have any symptoms. However, in some patients CPO can cause severe infections that are very difficult to treat. Surveillance for CPO began in 2012 at the BC Cancer Agency and 2014 at BC Children s and BC Women s. During , no cases were identified at PHSA facilities. Catheter-Related Blood Stream Infection PHSA agencies deliver highly specialized care in high risk areas such as oncology, neonatal and pediatric intensive care units. Many of the patients in these units have central venous catheters (CVCs) to provide necessary vascular access. However, it also puts patients at risk for local and systemic complications, including catheter-related blood stream infection (CRBSI). Pediatric Intensive Care Unit at BC Children s In 2015/16, three CRBSI cases were identified in PICU. The increase in CRBSI rate was not statically significant but merely reflects the small number of cases (three cases 2015/16 vs. one case in 2014/15). 18 P age
21 Figure 11: CRBSI rate at PICU unit at BCCH Cases per 1000 catheter days Incidence rate of CRBSI in Pediatric ICU at BCCH 2009/ / / / / / / / /16 CRBSI rate Neonatal Intensive Care Unit at BC Women s In 2015/16, an increased CRBSI rate was observed in NICU and the case number has increased to 29 cases from 13 cases last year. Figure 12: CRBSI rate at NICU unit at BC Children s Incidence rate of CRBSI in Neonatal ICU at BCWH 2008/9-2015/16 Cases per 1000 catheter days / / / / / / / / 16 CRBSI rate Surgical Site Infections Infection following surgery can lead to prolonged hospitalization, increased patient anxiety and overall health care costs. Therefore, surgical site infections (SSI) surveillance has become a universal measure of quality in surgical programs. BC Children s: The Department of Surgery joined the U.S.-based National Surgical Quality Improvement Program (NSQIP) in July 2011 to conduct pediatric SSI surveillance for selected surgical procedures, including post-discharge follow-up. Since then, IPAC at BC Children s has been working closely with the NSQIP team on identifying issues and implementing measures to prevent SSIs. 19 P age
22 BC Women s: Annually, over 2,000 caesarean sections (C-sections) are performed at BC Women s. Over the past few years, the IPAC Service has been working collaboratively with the Department of Obstetrics and Gynaecology to establish a reliable and sustainable C-section surveillance system. In February 2014, a pilot study was conducted by a research team at the hospital to test online patient reporting and a physician survey for collecting SSI information among patients who had C-sections. As a result, a new surveillance system was launched in January 2016, including a clinic designated to follow up patients who had C-sections at the hospital. Moving forward, IPAC will work closely with BC Women s leadership and the research team to identify SSI issues in a timely manner. In 2015/16, based on IPAC C-section surveillance findings, 17 SSI cases were identified, including 12 superficial incisional and five organ space infections. Figure 13: C-section SSI cases identified at BC Women s in 2015/16. # of SSI cases C-section associated SSI case identifed at BCW Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Tuberculosis at Forensic Psychiatric Hospital At Forensic Psychiatric Hospital surveillance for latent TB infection is conducted through tuberculin skin testing of compliant patients. In , 78 patients had negative tests while there were 12 patients that required chest x-ray follow up for positive tests. Eleven of those were reported as normal, and one was suggestive of latent TB but the patient was not considered a good candidate for prophylactic treatment. 20 P age
23 Outbreak Management Influenza Outbreaks: No influenza outbreaks were declared in any PHSA facilities in 2015/16. Gastroenteritis Outbreaks: Two laboratory confirmed norovirus outbreaks were declared at BC Children s Hospital in 2015/16. The average length of these outbreaks was 9.5 days. A multidisciplinary approach was taken to manage the outbreaks. Key actions included isolation of suspect and confirmed patients, restriction of admissions and transfers, enhanced decluttering, cleaning and disinfection, suspending group activities, cohorting staff and cases, and visitor notification. In order to minimize interruption of patient flow, units were divided with a barrier to allow for patient admissions in special circumstances. Key concerns identified during outbreak debrief meetings: Lessons Learned: Communication to all key stakeholders and frontline staff could be improved Actions Taken: Creation of an outbreak communication distribution list to include all key stakeholders Need for standardized procedure after hours Updating outbreak standards and developing an algorithm Need for an algorithm Creation of a Trigger Alert when there is increased gastroenteritis illness on a unit to prevent an outbreak from occurring Generic signage was not readily available Plans to create generic signage Staff were not always ordering the correct lab test Investigating the use of a viral panel for stool testing to simplify ordering 21 P age
24 Projects and Initiatives PHSA IPAC Perception Survey Between October 14 and November 7, 2015, the IPAC Service sent out an anonymous survey that targeted all PHSA employees, medical staff, and contracted providers (e.g. housekeeping, food services). The primary objective was to assess the perception of PHSA staff regarding IPAC services. IPAC received 668 responses, of which almost 80 per cent of responses were received from BCCA (n=228), BCCH (n=195) and BCWH (n= 107). Over half (59%) rated IPAC services in their workplaces as either good or excellent and satisfaction increased with frequency of IPAC contact (daily contact 69 per cent, weekly 64 per cent, monthly 60 per cent and yearly 55 per cent ). Awareness of IPAC information ranged from 17 per cent (annual report) to 96 per cent (hand hygiene information), but per cent of those who had accessed the information found it useful. Further analysis and communication of survey results is underway, and the IPAC team is using the results to inform priorities and activities for 2016/17 and beyond. Audits Various audits have been conducted this year to ensure IPAC practices are being upheld at PHSA and to prepare the different sites for accreditation. Audits completed at BCCH and BCWH include the operating rooms, the milk bank, the Cardiac Outpatient Clinic and the Pharmacy Compounding Room. Audits have also begun for Antibiotic Resistant Organism (ARO) screening to assess compliance at BCCH and BCWH. Audits that have been conducted at BCCA include soiled utility rooms (VIC: which resulted in renovation for better separation of clean/dirty items, CN), pet therapy audits (VIC), cleaning practices in the high dose rate (HDR) brachytherapy suite (VC, FVC), IC practices in the HDR brachytherapy suite (VC, FVC), cleaning practices in nutrition (FVC), cleaning practices in radiation therapy (FVC, CN) and food service practices with volunteer services (FVC). BC Children s and BC Women s C. difficile study Investigators from the IPAC team, including Dr. Ghada Al-Rawahi (principal investigator), Dr. Simon Dobson and Dr. Peter Tilley, are currently working with oncology to study the prevalence of C. difficile colonization in pediatric oncology patients at admission to hospital and to determine the true rate of health care-associated C. difficile infection in pediatric oncology patients Invasive fungal infection study Investigators from the IPAC team, including Dr. Ghada Al-Rawahi (principal investigator), Sarah Wells, June Collet and Dr. Simon Dobson, are collaborating with oncology in a study to assess the potential impact of major hospital construction on Invasive Fungal Infection rates among high risk oncology patients, when risk-appropriate measures have been implemented. 22 P age
25 BC Cancer Agency Electronic health record documentation ICPs at BC Cancer Agency have begun the process of electronic documentation of complex consults to improve interdisciplinary communication and continuity of care. High Risk Infectious Disease (HRID) Response Plan Key stakeholders at BC Cancer Agency Vancouver Centre have recognized the usefulness of building on the West African Ebola Response plan to create a general High Risk Infectious Disease (HRID) Response plan. This plan was initiated at the Vancouver Centre and will soon be adapted to remaining cancer centres at BC Cancer Agency. 23 P age
26 Future Directions Moving forward, we aim to achieve our vision of empowering everyone to prevent infections. Our priorities for and beyond are aligned with our mission statement and include the following: A proactive approach to current and evolving challenges Promotion of frontline ownership (FLO) One of the fundamental challenges in IPAC is achieving compliance with recommended practices, and organizational culture is a key factor. FLO is a culture change strategy based on the principle of bottom-up leadership and ownership from frontline staff. FLO seeks to target the way people interact with each other, which results in a change in group norms and organizational culture. IPAC team members across PHSA are starting to use elements of this approach, including facilitation tools known as Liberating Structures ( in their interactions with staff. We are also working on a communications plan to get this message across to PHSA staff. Physician engagement Physician engagement is fundamental to patient safety and quality care. IPAC will continue to engage PHSA physicians through residents orientation, IPAC presentations at division meetings/rounds, and regular communication of pertinent topics/updates. Facilitating implementations and solutions Hand hygiene campaign refresh The updated hand hygiene campaign will be rolled out across all PHSA agencies in Patient hand hygiene There is increasing recognition that infections may be acquired by patients from the healthcare environment via their own hands, but there has been relatively little emphasis to date on patient hand hygiene compared to health care worker hand hygiene. We will start implementing pilot projects in to assess and improve patient hand hygiene at BC Children s, BC Women s and the BC Cancer Agency. Expert consultation based on applicable regulations, evidence and best practice Accreditation With BCCDC, Forensics, BC Children s and BC Women s undergoing Accreditation Canada surveys in , the IPAC Service will play a key role in assessing and improving compliance with best practice standards. Audits Team members at BC Children s, BC Women s and the BC Cancer Agency will continue to increase the number of audits being performed to assess compliance with best practice. For there will be a new Reprocessing & Audit Specialist to lead this initiative. 24 P age
27 Infection control manuals We will continue to improve the content and formatting and develop a revision cycle for the manuals across all sites.- Construction Major construction projects will be continuing and starting at BC Children s, BC Women s, the BC Cancer Agency and Forensic Hospital in Our Construction Specialist will continue to provide consultative services and improve the processes of communication and implementation of IPAC precautions. Collaboration with local, provincial, and national partners Provincial signage PHSA IPAC representatives worked with the PICNet Education Committee to develop standardized Additional Precautions signs for the entire province. These will be rolled out across PHSA in Housekeeping The role of environmental cleaning is crucial in IPAC. The IPAC Service will continue to work with Housekeeping staff to ensure that policies and procedures are in alignment with best practice guidelines. IPAC Canada Oncology Interest Group As of January 2016, the BCCA IPAC team has been working with IPAC Canada on planning activities to revitalize the IPAC-Canada Oncology Interest Group. While in its initial stages, the plan for the interest group is to engage IPAC groups across Canada, in examining current practices and making best practice recommendations for issues unique to Oncology P age
28 Appendix A- PHSA IPAC Organizational Chart 26 P age
29 Appendix B Definitions Colonization: The presence, growth, and multiplication of an organism without observable clinical symptoms or immune reaction. The patient is asymptomatic. Infection: Invasion by and multiplication of a microorganism in body tissue resulting in clinical manifestations of disease. VRE case: Laboratory confirmation of vancomycin-resistant enterococci from specimens indicative of colonization or infection. This includes: o Cases identified for the first time during their hospital admission. o Cases identified previously at outpatient clinics but currently the patients being admitted with positive VRE isolates. o Cases identified in the emergency department that are admitted subsequently (during the same day). This does NOT include: o o o Cases identified in the emergency department but are not admitted. Cases identified in outpatient clinics or other outpatient cases. Case re-admitted with VRE. Health care-associated VRE: A VRE case (as defined above) identified greater than 3 calendar days after admission, OR a VRE case identified 3 calendar days or less after admission, but is related to a previous admission within the last 12 months MRSA case: Laboratory confirmation of methicillin-resistant Staphylococcus aureus from specimens indicative of colonization or infection. This includes: o Cases identified for the first time during their hospital admission. o Cases identified previously at outpatient clinics but currently the patients being admitted with positive MRSA isolates. o Cases identified in the emergency department that are admitted subsequently (during the same day). This does NOT include: o Cases identified in the emergency department but are not admitted. o Cases identified in outpatient clinics or other outpatient cases. o Case re-admitted with MRSA. Health care-associated MRSA: A MRSA case (as defined above) identified greater than 3 calendar days after admission, OR a MRSA case identified 3 calendar days or less after admission, but is related to a previous admission within the last 12 months. CDI case: Laboratory confirmation (positive toxin or culture with evidence of toxin production) of Clostridium difficile in an unformed stool specimen (does not include patients <1 year old). Primary CDI infection: The first episode of CDI ever experienced OR a new episode of CDI which occurs more than 8 weeks after the previous toxin-positive assay. 27 P age
30 Health care-associated CDI: A CDI case (including primary and relapse CDI cases) with symptom onset greater than 3 calendar days or more after admission, OR a CDI case with symptom onset in the community or 3 calendar days or less after admission, provided that symptom onset was less than 8 weeks after the last discharge. CPO case: Laboratory confirmation of carbapenem resistance/reduced susceptibility caused by a carbapenemase in specified Gram negative organisms, including Enterobacteriacae and Acinetobacter spp. Catheter-related bloodstream infection (CRBSI): A laboratory-confirmed bloodstream infection (BSI) where a catheter was in place for >2 calendar days on the date of the positive blood culture, with day of device placement being Day 1. Patient with BSI has met one of the following criteria: o OR o A recognized pathogen cultured from one or more blood cultures and unrelated to an infection at another site. At least one of: fever (>38 C), chills, hypotension (if aged < 1 yr: one of fever (> 38 C), hypothermia (< 36 C), apnea, or bradycardia) AND infection signs and symptoms/ positive laboratory results are not related to an infection at another site AND common skin contaminant cultured from 2 or more blood cultures drawn on separate occasions. Catheter includes: Non-tunneled CVC, coated or non-coated (e.g. pulmonary artery catheter) Tunneled infusion device (e.g. Hickman, Broviac, tunneled hemodialysis line) Peripherally inserted central catheter (PICC line) Implanted vascular access device (IVAD) Gastrointestinal outbreak: Three or more cases of gastroenteritis among patients, residents, or staff, that cannot be explained by admitting diagnoses or by non-infectious causes of symptoms (i.e. recent use of laxatives or stool softeners, chronic diarrhea, etc.), within a fourday period in the same unit or patient care area. Respiratory outbreak: Two or more cases of influenza-like illness (fever, chills, headache, myalgia, sore throat, cough, nasal congestion, etc.) among patients, residents, or staff within a one-week period in the same unit or patient care area. Patient days: Patient days are used as denominators in the calculation of rates to adjust for length of stay. It is calculated by the number of patients admitted (counts are usually conducted at midnight) and multiplied by the number of days of hospitalization in a given time period. 28 P age
INFECTION PREVENTION AND CONTROL ANNUAL REPORT. Prepared by: Provincial Health Services Authority Infection Prevention & August 2017
1 INFECTION INFECTION PREVENTION AND CONTROL PREVENTION ANNUAL REPORT Prepared by: April 2016 March 2017 Provincial Health Services Authority Infection Prevention & August 2017 s 2 Table of Contents Table
More informationINFECTION PREVENTION & CONTROL. ANNUAL REPORT April 2014 March 2015
INFECTION PREVENTION & CONTROL ANNUAL REPORT April 2014 March 2015 Prepared by: Provincial Health Services Authority Infection Prevention & Control (IPAC) November 2015 Table of Contents Executive Summary
More informationPHSA pledges safe healthcare for all. Together we can make a difference. Infection Prevention & Control Annual Report
PHSA pledges safe healthcare for all. Together we can make a difference. Infection Prevention & Control Annual Report 2009-2010 Table of Contents Executive Summary... 2 Executive Summary of Key HAI Indicators...
More informationProvincial Surveillance
Provincial Surveillance Provincial Surveillance 2011/12 Launched first provincial surveillance protocols Establishment of provincial data entry & start of formal surveillance reports Partnership with AB
More informationCMS and NHSN: What s New for Infection Preventionists in 2013
CMS and NHSN: What s New for Infection Preventionists in 2013 Joan Hebden RN, MS, CIC Clinical Program Manager Sentri7 Wolters Kluwer Health - Clinical Solutions Objectives Define the current status of
More informationConsumers Union/Safe Patient Project Page 1 of 7
Improving Hospital and Patient Safety: An overview of recently passed legislation and requirements towards improving the safety of California s hospital patients June 2009 Background Since 2006 several
More informationClostridium difficile
Clostridium difficile Michelle Luscombe & Karly Herberholz Hagel 5/14/2012 1 Outline What is clostridium difficile infection (CDI)? Symptoms & Complications Risk Factors Transmission Prevention and Control
More informationC. difficile Infection and C. difficile Lab ID Reporting in NHSN
C. difficile Infection and C. difficile Lab ID Reporting in NHSN MARY ANDRUS, BA, RN, CIC Infection Preventionist Consultant Learning Objectives Review the structure and of the MDRO/CDAD Module within
More informationGuidelines for the Management of C. difficile Infections in. Healthcare Settings. Saskatchewan Infection Prevention and Control Program November 2015
Guidelines for the Management of C. difficile Infections in Healthcare Settings Saskatchewan Infection Prevention and Control Program November 2015 Agenda What is C. difficile infection (CDI)? How do we
More informationHealthcare Acquired Infections
Healthcare Acquired Infections Emerging Trends in Hospital Administration 9 th & 10 th May 2014 Prof. Hannah Priya HICC In charge What is healthcare acquired infection? An infection occurring in a patient
More informationDecreasing Nosocomial C. diff
Decreasing Nosocomial C. diff Our journey to decreasing nosocomial C. diff Jennifer Conti BSN, RN, CIC Nicole Rabic MSN, RN, CIC 4.21.2016 Nosocomial C. diff Use of the CDC standardized definition Review
More informationPrairie North Regional Health Authority: Hospital-acquired infections
Prairie North Regional Health Authority: Hospital-acquired infections Main points... 308 Introduction... 309 Background the risk of hospital-acquired infections... 309 Audit objective, scope, criteria,
More informationNOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION
NOSOCOMIAL INFECTION : NURSES ROLE IN MINIMIZING TRANSMISSION DR AHMAD SHALTUT OTHMAN JAB ANESTESIOLOGI & RAWATAN RAPI HOSP SULTANAH BAHIYAH ALOR SETAR, KEDAH Nosocomial infection Nosocomial or hospital
More informationInfection Prevention and Control
Infection Prevention and Control Infection Prevention and Control Program IPAC program consists of three healthcare professionals IPAC department is located on the 9 th floor and is available Monday to
More information2014 Partnership in Prevention Award. November 21, :00-1:00PM EST. Introduction
2014 Partnership in Prevention Award November 21, 2014 12:00-1:00PM EST Introduction Don Wright, MD, MPH Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion) U.S. Department
More informationDirect cause of 5,000 deaths per year
HOSPITAL ACQUIRED (NOSOCOMIAL) INFECTION Policies MRSA Policy Meningitis Policy Blood and body fluid Exposure Policy Disinfection Policy Glove Policy Tuberculosis Policy Isolation Policy DEFINITION: ANY
More informationJoint Commission NPSG 7: 2011 Update and 2012 Preview
Joint Commission NPSG 7: 2011 Update and 2012 Preview Pharmacy OneSource Webinar June 1, 2011 Louise M. Kuhny, RN, MPH, MBA, CIC The Joint Commission Objectives Upon completion of this program, participants
More informationExecutive Summary. IPC Annual Report to Alberta Health 1
Executive Summary This Alberta Health Services (AHS) annual report of Infection Prevention and Control (IPC) activities is submitted as required by the Alberta Health (2011) Standards for IPC Accountability
More informationHow to Add an Annual Facility Survey
Add an Annual Facility Survey https://nhsn.cdc.gov/nhsndemo/help/patient_safety_component/how_to/add_an_annual... Page 1 of 1 10/9/2017 Show Patient Safety Component > How To > Facility > Add an Annual
More informationCanadian Nosocomial Infection Surveillance Program (CNISP)
Canadian Nosocomial Infection Surveillance Program (CNISP) 2018 Surveillance of Vancomycin Resistant Enterococci Bloodstream Infections in CNISP Hospitals Revised January 29, 2018 Working Group: Stephanie
More informationInfection Prevention & Control Engaging Stakeholders
Infection Prevention & Control Engaging Stakeholders Annual Report for 2010-2011 Nov 2011 Petra Welsh, Director Tara Donovan, Epidemiologist www.fraserhealth.ca respect caring trust 1/60 INFECTION PREVENTION
More informationState of California Health and Human Services Agency California Department of Public Health
State of California Health and Human Services Agency California Department of Public Health MARK B HORTON, MD, MSPH Director ARNOLD SCHWARZENEGGER Governor AFL 10-07 TO: General Acute Care Hospitals SUBJECT:
More informationLightning Overview: Infection Control
Lightning Overview: Infection Control Gary Preston, PhD, CIC, FSHEA Terry Caton, CIC Carla Ward, CIC 2012 Healthcare Management Alternatives, Inc. Objectives At the end of this module you will know: How
More informationPOLICY & PROCEDURE POLICY NO: IPAC 3.2
POLICY & PROCEDURE POLICY NO: IPAC 3.2 SUBJECT SUPERCEDES August 2007, July 2008 S 1of 5 APPROVAL: Infection Prevention & Control Committee DATE: September, 2010 Professional Advisory Committee DATE: January
More informationCarbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas
Carbapenemase Producing Enterobacteriaceae (CPE) Prevention and Management Toolkit for Inpatient Areas This toolkit includes examples advice leaflets and forms which may be helpful for use by teams or
More informationInvestigating Clostridium difficile Infections
CALIFORNIA DEPARTMENT OF PUBLIC HEALTH Investigating Clostridium difficile Infections Erin P. Garcia, MPH, CPH Healthcare-Associated Infections (HAI) Program Center for Health Care Quality California Department
More informationCLABSI Prevention Hardwiring Improvement
CLABSI Prevention Hardwiring Improvement Brian Koll MD, FACP, FIDSA Executive Director, Infection Prevention Mount Sinai Health System Professor of Medicine, Icahn School of Medicine September 29, 2014
More informationIC CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017
IC.04.03 CONTACT and CONTACT PLUS PRECAUTIONS REV. JULY 2017 Standard In addition to Routine Practices, Contact Precautions or Contact Plus Precautions will be used for patients known or suspected to have
More informationLABORATORY-IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE. National Healthcare Safety Network (NHSN)
LABORATORY-IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE National Healthcare Safety Network (NHSN) CMS PARTICIPATION Acute care hospitals, Long Term Acute Care (LTACs),IP Rehabilitation
More informationProvincial Surveillance Protocol for Clostridium difficile infection
Provincial Surveillance Protocol for Clostridium difficile infection Table of Contents Background... 3 Clostridium difficile infection surveillance... 3 Purpose:... 3 Impact of Clostridium difficile infection:...
More informationOrientation Program for Infection Control Professionals
Orientation Program for Infection Control Professionals Module 1: Introduction and Four-Week Schedule Table of Contents Module 1: Introduction... 2 Note to Managers... 2 IPC Orientation Program... 3 Four-Week
More informationHOSPITAL EPIDEMIOLOGY AND INFECTION CONTROL: SURGICAL SITE INFECTION REPORTING TO CALIFORNIA DEPARTMENT OF PUBLIC HEALTH
Office of Origin: Department of Hospital Epidemiology and Infection Control (HEIC) I. PURPOSE To comply with reporting cases of surgical site infection as required by Sections 1255.8 and 1288.55 the California
More informationWRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT
WRIGHTINGTON, WIGAN AND LEIGH HEALTH SERVICES NHS TRUST DIRECTOR OF INFECTION PREVENTION AND CONTROL ANNUAL REPORT 2006-2007 Author(s) Gill Harris, Director of Infection Prevention and Control EXECUTIVE
More informationCDPH HAI Program Overview
CDPH HAI Program Overview San Diego APIC Chapter San Diego January 11, 2017 Lynn Janssen, Chief Healthcare-Associated Infections Program Center for Health Care Quality California Department of Public Health
More informationBackground of Initiative
Outline 2 Background of Initiative 3 Development of Recommendations 4 5 6 Development and Recommendations 7 Routine Practices Based on the premise that: All patients are potentially infectious (even if
More informationMaureen Spencer, RN, BSN, M.Ed., CIC Corporate Director, Infection Prevention Universal Health Services King of Prussia, PA
Maureen Spencer, RN, BSN, M.Ed., CIC Corporate Director, Infection Prevention Universal Health Services King of Prussia, PA UHS has an Acute Care Division that provides high quality care at 26 hospitals
More informationInfectious Diseases- HAI Tennessee Department of Health, Healthcare Associated Infections and Antimicrobial Resistance Program/ CEDEP
Infectious Diseases- HAI Tennessee Department of Health, Healthcare Associated Infections and Antimicrobial Resistance Program/ CEDEP Nashville, Tennessee Assignment Description The Fellow will be located
More informationAntibiotic Use and Resistance in Nursing Homes
Antibiotic Use and Resistance in Nursing Homes GHINWA DUMYATI, MD PROFESSOR OF MEDICINE CENTER FOR COMMUNITY HEALTH UNIVERSITY OF ROCHESTER MEDICAL CENTER FEBRUARY 8, 2017 Nicolle LE, et al. Antimicrobial
More informationINFECTION C ONTROL CONTROL CONTROL EDUCATION PROGRAM
INFECTION CONTROL EDUCATION PROGRAM Isolation Precautions Isolating the disease not the patient The Purpose is To protect compromised patient from environment To prevent the spread of communicable diseases.
More informationNational Standards for the prevention and control of healthcare-associated infections in acute healthcare services.
National Standards for the prevention and control of healthcare-associated infections in 2017 1 Safer Better Care Note on terms and abbreviations used in these standards A full range of terms and abbreviations
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationRecommendation II. Recommendation I. Who s on Your Team? Recommendation III
Infection Prevention In the Surgical Suite Janie Kinsey, RN, CASC Administrator, St. Luke s South Surgery Center President, Kansas Association of Ambulatory Surgery Centers Objectives Recommendation I
More informationPrevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015
Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in
More informationSelf-Instructional Packet (SIP)
Self-Instructional Packet (SIP) Advanced Infection Prevention and Control Training Module 4 Transmission Based Precautions February 11, 2013 Page 1 Learning Objectives Module One Introduction to Infection
More informationThe Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA
The Role of Isolation and Contact Precautions in the Elimination of Transmission of MRSA Marcia Patrick, RN, MSN, CIC Infection Control Director MultiCare Health System Tacoma, WA APIC/BD MRSA Presentation
More informationTRUST BOARD. Date of Meeting: 05/10/2010
TRUST BOARD Date of Meeting: 05//20 Enclosure: 7 Agenda Item No: 8.3 Title of Report: Interim Report for Infection Prevention and Control 20-2011 Aims: To inform the Board of the work of the Trust in controlling
More informationInfection prevention & control
Infection control in Australian medical practice: Current practice and future developments John Ferguson Infectious Diseases & Microbiology Director, Infection Prevention & Control, Hunter New England
More informationReducing the risk of healthcare associated infection
i Reducing the risk of healthcare associated infection Healthcare associated infection Introduction The Royal Marsden takes the safety of our patients very seriously. That means doing everything we can
More informationClostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions
Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP
More informationAn act to add Sections and to the Health and Safety Code, relating to health.
Senate Bill No. 1058 CHAPTER 296 An act to add Sections 1255.8 and 1288.55 to the Health and Safety Code, relating to health. [Approved by Governor September 25, 2008. Filed with Secretary of State September
More informationInfection Control and Prevention On-site Review Tool Hospitals
Infection Control and Prevention On-site Review Tool Hospitals Section 1.C. Systems to Prevent Transmission of MDROs Ask these questions of the IP. 1.C.2 Systems are in place to designate patients known
More informationHealth Care Associated Infections in 2015 Acute Care Hospitals
Health Care Associated Infections in 2015 Acute Care Hospitals Alfred DeMaria, M.D. State Epidemiologist Bureau of Infectious Disease and Laboratory Sciences Katherine T. Fillo, Ph.D, RN-BC Quality Improvement
More informationClostridium difficile Infection (CDI) Trigger Tool
Hospital ward/clinical Area Date Trigger Tool Commenced Date Trigger Tool Closed Person closing the CDI Trigger Health Protection Scotland March 2014 Version 3.0 A CDI trigger is the number of new CDI
More informationInfection Prevention. Fundamentals of. March 21-23, 2017 Oregon Medical Association Portland, OR. oregonpatientsafety.org
Fundamentals of Infection Prevention A Comprehensive Training Course for Infection Prevention Professionals March 21-23, 2017 Oregon Medical Association Portland, OR oregonpatientsafety.org Course Information
More informationLABORATORY IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE. National Healthcare Safety Network (NHSN)
LABORATORY IDENTIFIED (LABID) EVENT REPORTING MRSA BACTEREMIA AND C. DIFFICILE National Healthcare Safety Network (NHSN) CMS PARTICIPATION Acute care hospitals, Long Term Acute Care (LTACs),IP Rehabilitation
More informationTRANSMISSION-BASED PRECAUTIONS
TRANSMISSION-BASED PRECAUTIONS PRECAUTIONS Standard Precautions infection prevention practices used with all patients regardless of suspected or confirmed diagnosis. Based on the principle that all blood,
More informationErlanger Infection Control Program. Resident Resident Orientation and. and
Erlanger Infection Control Program Resident Resident Orientation Orientation and and Bloodborne Bloodborne Pathogen Pathogen Review Review 2008-2009 2009 1 Outline 1. Healthcare associated infections 2.
More informationNew Jersey State Department of Health and Senior Services Healthcare-Associated Infections Plan 2010
New Jersey State Department of Health and Senior Services Healthcare-Associated Infections Plan Introduction The State of New Jersey has been proactive in creating programs to address the growing public
More informationRecommendations for Isolation Precaution Step Down and Discharge of Persons Under Investigation or Confirmed Ebola Virus Disease Patients
Recommendations for Isolation Precaution Step Down and Discharge of Persons Under Investigation or Confirmed Contents A. Preamble... 2 B. Background and Clinical Course of EVD... 2 C. Persons Under Investigation:
More informationTHE INFECTION CONTROL STAFF
INFECTION CONTROL THE INFECTION CONTROL STAFF INTEGRIS BAPTIST V. Ramgopal, M.D., Hospital Epidemiologist Gwen Harington, RN, BSN, CIC, Infection Control Specialist Kathy Knecht, RN, Surveillance Coordinator
More informationTaking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent
Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 3 Strategies to prevent Nimalie D. Stone, MD,MS Division of Healthcare Quality Promotion National
More informationREPORT SUMMARY SHEET
Quality care for you, with you REPORT SUMMARY SHEET Meeting: Date: Title: Lead Director: Corporate Objective: Purpose: High level context: Trust Board 27 th October 2016 Infection Prevention and Control
More informationQUALIS HEALTH HONORS WASHINGTON HEALTHCARE PROVIDERS
LEADERSHIP IN IMPROVING HEALTHCARE Harborview Medical Center Code Sepsis: Improving Survival in Sepsis with Early Identification and Activation of a Critical Care Team Sepsis, one of the highest causes
More informationNHS Highland Infection Prevention & Control Annual Work Plan End of Year
NHS Highland Board 5 April Item 5.7 NHS Highland & Control Annual Work Plan End of Year Update for COIC Prepared by Catherine Stokoe and Jonty Mills (as of 01/03/) Objective Activity Time Scale Lead Officer
More informationClostridium difficile Infection (CDI) Surveillance: Application of the Case Definition in a Regional Health Authority in BC
Clostridium difficile Infection (CDI) Surveillance: Application of the Case Definition in a Regional Health Authority in BC Louis Wong, Janie Nichols, Tara Leigh Donovan IPAC Canada 2017 National Education
More informationHEI self-assessment. Completing the self-assessment - Guidance to NHS boards
HEI self-assessment Completing the self-assessment - Guidance to NHS boards INTRODUCTION This document should be read in conjunction Healthcare Improvement Scotland healthcare associated infection (HAI)
More informationHealth Care Associated Infections in 2017 Acute Care Hospitals
Health Care Associated Infections in 2017 Acute Care Hospitals Christina Brandeburg, MPH Epidemiologist Katherine T. Fillo, Ph.D, RN-BC Director of Clinical Quality Improvement Eileen McHale, RN, BSN Healthcare
More informationInfection Prevention and Control for Phlebotomy
Page 1 of 10 POLICY STATEMENT: It is Sunnybrook s Policy to prevent the spread of infection within the health care institution from patient to patient, patient to staff, staff to patient by: a) providing
More informationVancomycin-Resistant Enterococcus (VRE)
Approved by: Vancomycin-Resistant Enterococcus (VRE) Vice President & Chief Medical Officer Corporate Policy & Procedures Manual VI-40 Date Approved July 14, 2016 August 12, 2016 Next Review (3 years from
More informationInfection Prevention and Control
Infection Prevention and Control Infection Control in the Healthcare Setting Chain of Infection Hand Hygiene Hospital Acquired Infections Isolation Exposures Tuberculosis Chain of Infection Most Common
More informationPICNet Community of Practice Survey Responses from PICNet to the Community of Practice and Summary of Next Steps
PICNet Community of Practice Survey 2015 Responses from PICNet to the Community of Practice and Summary of Next Steps Prepared by: Provincial Infection Control Network of British Columbia (PICNet) August
More informationOrganizational Structure Ossama Rasslan
Organizational Structure Chapter 2 Organizational Structure Ossama Rasslan Key points Risk prevention for patients and staff is a concern of everyone in the facility and must be supported at the level
More informationInfection Prevention Control Team
Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee
More informationHAI Prevention. Beyond the Bundle. March 18, 2016
HAI Prevention Beyond the Bundle March 18, 2016 Krystyna Strozewski Director of Quality Lake Health System Karen Mrazik Infection Preventionist Tripoint Medical Center Elizabeth Reed Infection Preventionist
More informationSECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)
SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication
More informationJanuary Alberta Infection Prevention and Control Strategy
January 2008 Alberta Infection Prevention and Control Strategy For further information For additional copies of this document contact: 22nd floor, 10025 Jasper Avenue Edmonton, Alberta T5J 1S6 Phone: 780-427-7164
More informationEmergency Department Isolation Precautions
Carolinas HealthCare System Department of Infection Prevention I. SCOPE Emergency Department Isolation Precautions This policy applies to all Carolinas HealthCare System Emergency Department (ED) locations
More informationAPPLICATION. Thank you for your interest in applying for the APIC Program of Distinction.
APPLICATION Thank you for your interest in applying for the APIC Program of Distinction. This application has three parts: u PART 1: u PART 2: Personnel Information u PART 3: Required Documents Facilities
More informationInfection Prevention and Control Annual Education 2010
Infection Prevention and Control Annual Education 2010 Authored by: Cathy Clark, RN MPH CIC Mary Whitaker, RN CIC Bola Ogundimu, RN MPH Marie Commiskey, RN CCRN CIC Modified for affiliated schools students
More informationOutbreak Management. Gastroenteritis Outbreak Protocol
INFECTION PREVENTION AND CONTROL (IPAC) Outbreak Management Gastroenteritis Outbreak Protocol Infection Prevention and Control Guidelines for Acute and Residential Care R:Infection Control Manual\Outbreak
More informationTell Your Story with a Well- Designed Data Plan. Jackie McFarlin, RN, MPH,MSN, CIC VA North Texas Health Care System
Tell Your Story with a Well- Designed Data Plan Jackie McFarlin, RN, MPH,MSN, CIC VA North Texas Health Care System Purposes of Presentation Describe the elements of a well designed data plan Guidelines
More informationBeth Ann Ayala, Jim Lewis, and Tom Patterson DATE. Educating for Quality Improvement & Patient Safety
Beth Ann Ayala, Jim Lewis, and Tom Patterson DATE Educating for Quality Improvement & Patient Safety 1 The Team CSE participants Tom Patterson,MD - Professor of Medicine Division Head and Chief, Infectious
More informationKey prevention strategies for MRSA bacteraemia: a case study. Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta
Key prevention strategies for MRSA bacteraemia: a case study Dr. Michael A. Borg Director of Infection Prevention & Control Mater Dei Hospital Malta 1 Mortality following Staphylococcus aureus bacteraemia
More informationSECTION: PATIENT RELATED INFECTION CONTROL NUMBER: 2.1 TRANSMISSION BASED PRECAUTIONS
University of Connecticut Health Center Page 1 of 8 SECTION: PATIENT RELATED INFECTION CONTROL NUMBER: 2.1 TRANSMISSION BASED PRECAUTIONS PURPOSE: Transmission-Based s are designed for patients documented
More informationNosocomial Infection in a Teaching Hospital in Thailand
Nosocomial Infection in a Teaching Hospital in Thailand Somsak Lolekha, M.D., Ph.D.,* Banchong Ratanaubol R.N.** and Pranom Manu R.N.** (*Department of Pediatrics; **Department of Nursing, Faculty of Medicine
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationESRD Network 5: Prevention Process Measure Training Christi Lines, MPH
ESRD Network 5: Prevention Process Measure Training Christi Lines, MPH January 26, 2016 Outline Overview of NHSN surveillance Brief review of Dialysis Event surveillance The value of auditing prevention
More information1.2 billion ambulatory care visits in US: physician offices, outpatient hospital and ED
Overview More patients obtain healthcare in specialty clinics and physicians offices in the United States than in hospitals 1.2 billion ambulatory care visits in US: physician offices, outpatient hospital
More informationInfection Control Prevention Strategies. For Clinical Personnel
Infection Control Prevention Strategies For Clinical Personnel What is Infection Control? Infection Control is EVERYONE s responsibility It protects patients, employees and visitors by preventing and controlling
More informationPresented by: Mary McGoldrick, MS, RN, CRNI
Infection Prevention and Control Challenges in the Home and Community based Care Mary McGoldrick, MS, RN, CRNI Home Care and Hospice Consultant Saint Simons Island, GA Nothing to Disclose Top 5 Home Care
More informationMMI 408 Spring 2011 Group 1 John Wong. Statement of Work for Infection Control Systems
MMI 408 Spring 2011 Group 1 John Wong Statement of Work for Infection Control Systems Monday, April 11, 2011 Table of Contents 1 Background... 3 2 Project Objectives... 4 3 Scope... 5 3.1 Included... 5
More informationReport of the unannounced inspection at Wexford General Hospital.
Report of the unannounced inspection of the prevention and control of healthcare associated infection at X Hospital Report of the unannounced inspection at Wexford General Hospital. Monitoring programme
More informationISOLATION PRECAUTIONS INTRODUCTION. Standard Precautions are used for all patient care situations, but they
ISOLATION PRECAUTIONS INTRODUCTION Standard Precautions are used for all patient care situations, but they may not always be sufficient. If a patient is known or suspected to be infected with certain pathogens
More informationInfection Prevention, Control & Immunizations
Infection Control: This facility task must be used to investigate compliance at F880, F881, and F883. For the purpose of this task, staff includes employees, consultants, contractors, volunteers, and others
More informationIsolation Care of Patients in Isolation due to Infection or Disease
Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection
More informationCommunicable Disease Control Manual Chapter 4: Tuberculosis
Provincial TB Services 655 West 12th Avenue Vancouver, BC V5Z 4R4 www.bccdc.ca Communicable Disease Control Manual July, 2018 Page 1 TABLE OF CONTENTS APPENDIX B: INFECTION PREVENTION AND CONTROL... 2
More informationAORN Recommended Practices for Environmental Cleaning (2014) APIC Chapter San Diego and Imperial County
Salah S. Qutaishat, PhD, CIC, FSHEA AORN Recommended Practices for Environmental Cleaning (2014) APIC Chapter 057 - San Diego and Imperial County Describe the importance of a clean environment. Define
More informationLearning Objectives. John T. Mather Memorial Hospital
Bringing Molecular Testing into the Clinical Lab: Effectiveness of Rapid Methicillin-Resistant Staphylococcus Aureus (MRSA) Screening in Reducing Hospital Acquired Infections Denise Uettwiller-Geiger,
More information2014 Annual Continuing Education Module. Contents
This self-directed learning module contains information you are expected to know to protect yourself, our patients, and our guests. Content Experts: Infection Prevention Target Audience: All Teammates
More informationCDI Preventing and Managing Clostridium Difficile - A Provider's Perspective
Thank You for Joining! CDI Preventing and Managing Clostridium Difficile - A Provider's Perspective New England Nursing Home Quality Care Collaborative Webinar Will Begin Shortly. Call-In Number: (888)
More information